NCT00520975-D2
Dataset Information
Dataset ID: NCT00520975-D2
PubMed ID (PMID):
Publication Title:
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Description of Dataset:
There are two submissions for PMID 38967884. This dataset, NCT00520975-D2, contains toxicity data. Dataset NCT00520975-D1 contains baseline, treatment, and efficacy data.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT00520975 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®